Recruiting

Observational Study

Sponsor:

Centre hospitalier de l'Université de Montréal (CHUM)

Code:

NCT03378856

Conditions

Cancer

Radiotherapy Side Effect

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Study Details

Brief summary:

Prospective cohort study of patients receiving standard-care radiotherapy is paramount to a better understanding of radiation effects and longterm outcomes.

The primary objective is to determine the feasibility of establishing infrastructure to systematically collect clinical data, patient-reported outcomes, and imaging data from daily radiotherapy practice.

Secondary objectives are to provide a control cohort for comparative effectiveness research of investigational interventions through a cmRCT design; compare imaging features with clinical outcomes; understand dose-effect relationships; quantify imaging quality metrics.

Conditions

Cancer

Radiotherapy Side Effect

Study ID

NCT03378856

Start date

Nov 1, 2017

Status verified date

Aug, 2026

Completion date

Oct, 2040

Anticipated

Primary completion date

Oct, 2040

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Inclusion Criteria:

  • Ability to provide informed consent
  • Receiving radiotherapy or brachytherapy

Exclusion Criteria:

\-

Study Design

Enrollment

1500 participants

Anticipated

Interventions and Outcome Measures

Primary outcome measure

  • Accrual rates [ Time Frame: 2 years ]

Central Contacts and Locations

Central contacts

Locations

BC Cancer - Kelowna

Recruiting

Kelowna, British Columbia, Canada

Contacts

Principal Investigator:

Katie Jasper, MD

BC Cancer - Vancouver

Recruiting

Vancouver, British Columbia, Canada, V5Z 4E6

Contacts

Principal Investigator:

Srinivas Raman, MD

London Health Regional Cancer Centre

Recruiting

London, Ontario, Canada, N6C 2R5

Contacts

Principal Investigator:

Pencilla Lang, MD

Sunnybrook Research Institute

Recruiting

Toronto, Ontario, Canada, M4N 3M5

Contacts

Principal Investigator:

Amir Safavi, MD

Princess Margaret Cancer Centre

Recruiting

Toronto, Ontario, Canada

Contacts

Principal Investigator:

Philip Wong

CISSS de Laval - Hôpital de la Cité-de-la-Santé

Recruiting

Laval, Quebec, Canada

Contacts

Principal Investigator:

Danny Duplan, MD

Research Institute of the McGill University Health Center

Recruiting

Montreal, Quebec, Canada, H3H 2R9

Contacts

Principal Investigator:

Fabio Cury, MD

Centre Hospitalier de l'Université de Montréal

Recruiting

Montreal, Quebec, Canada

Contacts

Principal Investigator:

Cynthia Ménard, MD

CHU de Québec - Université Laval

Recruiting

Québec, Quebec, Canada

Contacts

Principal Investigator:

Eric Vigneault, MD

More Information

Sponsor

Centre hospitalier de l'Université de Montréal (CHUM)

Last update posted

Sep 1, 2026

Last verified

Aug, 2026

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Centre hospitalier de l'Université de Montréal (CHUM) on 2026-09-01.